NCT03504644 2026-05-13Venetoclax and Vincristine in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblastic LeukemiaEastern Cooperative Oncology GroupPhase 1/2 Active not recruiting40 enrolled 18 charts